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Abstract: Polymorphonuclear leukocytes (PMNs) ad-
herent to fibrinogen exhibit a delay in the release of H202
in response to fMLP. Previously, we demonstrated that
H202 release in adherent PMNs coincides with the exocy-
tosis of lactoferrin-containing specific granules and acti-
vation of phospholipase D (PLD). We also found that che-
lation of intracellular calcium blocked both lactoferrin
and H202 release in stimulated PMNs in spite of the fact
that adhesion and spreading remained normal. Since
diradylglycerol (DRG) formation has been implicated in
PMN secretion and oxidant release, we determined the
effect of intracellular calcium chelation on PLD activa-
tion and DRG formation to ascertain whether DRG for-
mation was coupled to lactoferrin and H202 release. We
observed that chelation of intracellular calcium with bis-
(O-aminophenoxy)-ethanol-N,N;I%7’- tetraacetic acid (BAPTA)
prevented PLD activation as monitored by inhibition of
phosphatidylethanol formation. Formation of DRG der-
ived from phosphatidic acid (PA) was also inhibited in
the presence of BAPTA. Following the addition of the cal-
cium ionophore ionomycin to the BAPTA-treated PMNs,
lactoferrin and H202 release was coincident with the on-
set of DRG formation. Also the addition of sn-1,2-dide-
canoylglycerol to the BAPTA-treated PMNs stimulated
them to release H202. Our studies support the hypothesis
that DRG derived from PLD activation is required for
degranulation of specific granules and associated H202
release from adherent PMNs. J. Leukoc. Biol. 56:
105-109; 1994.
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INTRODUCTION
Previously, we correlated the exocytosis of lactof#{232}rrin-
containing specific granules and H202 release in polymor-
phonuclear leukocytes (PMNs) by taking advantage of the
long lag period and protracted kinetics ofoxidant generation
in adherent PMNs [1]. The correlation observed between the
release of LF-containing specific granules and H202 in ad-
herent PMNs is consistent with the concept that transloca-
tion of an active NADPH oxidase from the specific granule
membranes to the plasma membranes results in the delivery
of H202 to the external milieu. Ultrastructural and subcellu-
lar fractionation studies have shown that cytochrome b558
plays a critical role in the assembly of the cytosolic compo-
nents 47Ph0 and p67Ph0, which leads to the generation of
021H202 by PMNs in suspension [2, 1 About 85% of the
total cytochrome b558 is associated with LF-containing
specific granule fractions in unactivated PMNs and the re-
mainder with the plasma membrane [3]. Therefore, it is not
surprising that in employing a cell-free system, an active
NADPH oxidase can be assembled on both plasma mem-
branes and specific granules, both of which contain
cytochrome b558 [4, 5]. Likewise, in adherent PMNs the
NADPH oxidase can be assembled on specific granules and
this assembled oxidase can be linked to the release of 02
into phagosomes [6].
We previously observed that diradylglyccrol (DRG) in-
creased following phospholipase D activation and was cor-
related with the exocytosis of LF-bearing specific granules
and H202 release [7]. We also found that chelation of in-
tracellular calcium blocked both LF and H202 release in
stimulated PMNs, in spite of the fact that adhesion and
spreading remained normal [1]. Since DRG has been impli-
cated in PMN secretion and oxidant release (8], we deter-
mined the effect of intracellular calcium chelation on PLD
activation and DRG formation in order to ascertain whether
DRG formation remained coupled to LF and H202 release
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Fig. 1. Effect of BAPTA on the time course of H202 release, LF release, and
DRG formation from PMNs plated onto fibrinogen and activated with
fMLP. (A) PMNs (1 x l05/ml) were added to fibrinogen-coated 24-well
plates containing 100 nM fMLP in the presence (#{149},A) and absence (0, L)
of 10 jzM BAPTA. The plates were then incubated at 37#{176}Cand samples
withdrawn at varying times and monitored for LF and H2O2 release. Values
represent the mean ± so of three separate experiments. (B) In parallel
wells, DRG formation was determined over the same time interval for
fMLP-stimulated PMNs in the presence (#{149})or absence (0) of 10 sM
BAPTA. Values represent the mean ± SD of three separate experiments.
An asterisk (‘) indicates values that are significantly different (P < .01)
from controls at time 0.
Although there was a correlation between LF and H202
release in adherent PMNs, it was not clear whether the ex-
ocytosis of LF-containing granules was required for H202
generation. Therefore, we employed the intracellular cal-
cium chelator BAPTA to block the exocytosis of LF-
containing specific granules and determined the effect of this
treatment on H202 release. BAPTA-treatment of the PMNs
significantly inhibited (P < .01) fMLP-mediated LF and
H202 release in adherent PMNs (Fig. 1A). When PMNs
were plated onto fibrinogen and stimulated with fMLP un-
der the conditions that promote LF and H202 release, we ob-
served two peaks of DRG formation as noted previously [7].
The initial increase in DRG was similar in magnitude to the
DRG levels reported for PMNs activated with fMLP in sus-
pension. The second phase of DRG generation occurs
through a PLD-mediated pathway and corresponds to
degranulation and oxidant release in PMNs adherent to
fibrinogen [7]. As shown in Figure 1B, BAPTA treatment
blocked the second the phase of DRG generation without
affecting the first phase.
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conjugated goat anti-rabbit antibodies from Organon-
Teknika Corp. (Malverne, PA). sn-1,2-Didecanoylglycerol
was obtained from Avanti Polar-Lipids (Alabaster, AL). 10
Neutrophil preparation and functional assays
Human PMNs were isolated from human peripheral blood
as previously described [9] using dextran sedimentation fol-
lowed by hypotonic lysis to remove the majority of erythro-
cytes and centrifugation through Ficoll-Paque. Assays were
conducted in 24-well, flat-bottom, polystyrene Falcon
Primaria tissue culture plates coated with fibrinogen (50
jg/ml) as previously outlined [10]. To measure H202 release,
PMNs (1 x 105/well) suspended in KRBG were added to
fibrinogen-coated wells containing Krebs-Ringer phosphate
buffer with glucose (KRBG), 24 M scopoletin, 5 g of
horseradish peroxidase, 1 mM sodium azide, and the mdi-
cated agonists and/or inhibitors in a final volume of 1 ml [1].
Samples were also evaluated for LF content [1].
DRG formation in PMNs plated onto fibrinogen
PMNs were plated onto fibrinogen-coated 24-well plates un-
der the same experimental conditions as those outlined for
H202 release [7]. At the indicated time points, PMNs from
eight wells were extracted according to the method of Shay-
man et al. [11] as combined as recently described [7]. DRG
was quantified by enzymatic conversion of DRG to [32P]PA
using E. co/i diacylglycerol kinase [12, 7]. The protein con-
centration of each sample was determined using the Pierce
BCA protein assay reagent (Pierce, Rockford, IL).
BAPTA loading of PMNs
PMNs (1.3 x 106/ml) were incubated with the intracellular
Ca2 chelator BAPTA at 10 M in Ca2-free phosphate-
buffered saline (PBS) for 30 mm at 37#{176}C.At the end of this
incubation, 1 x 10 cells were added directly to fibrinogen-
coated wells containing prewarmed KRBG with 100 nM
fMLP and Ca2 and assayed for H202, LF release, and DRG
formation at various times [1, 7].
Labeling of PMNs with [3HJIy50PAF
For assessment of phosphatidylethanol (PEt) formation,
PMNs were prelabeled with lyso-PAF. PMNs (1 x 107/ml)
were incubated in [3H]lysoPAF (108 M) for 30 mm at 37#{176}C
as previously described [14]. After labeling, PMNs were
pelleted at 300g for 5 mm, washed twice with PBS, and
resuspended in PBS containing 1 mM Ca2 and Mg2.
PMNs were then preincubated in ethanol (200 mM) or
buffer for 5 mm at 37#{176}Cbefore plating onto fibrinogen-
coated plates, with ethanol being present throughout the
time course. Lipids were obtained and analyzed as previ-
ously described [7].
Statistical analysis
Data were analyzed by Student’s paired t-tests.
RESULTS
Effect of BAPTA on H202 and Iactoferrin release and
DRG formation in PMNs plated onto fibrinogen
Previously, we found a correlation between LF exocytosis
and Hi02 release in PMNs plated onto fibrinogen-coated
plastic and activated with fMLP [1]. As noted in Figure 1A,
















Reversal of BAPTA/AM treatment on adherent PMN
function
Following the addition of ionomycin to indo-1/AM-labeled
PMNs in the presence or absence of BAPTA/AM, intracellu-
lar Ca2 can be restored to very high levels in both resting
and agonist-stimulated PMNs [6]. We therefore assessed the
effect of ionomycin on adherent PMNs. Addition of 100 nM
ionomycin to the BAPTA-treated adherent PMNs at 90 mm
resulted in significant release of both H202 and LF within
15 mm (Fig. 2A). The generation ofDRG following addition
of ionomycin at 90 mm coincided with the onset of H202 and
LF release, suggesting an association between these events
(Fig. 2B). These studies indicate that PLD-mediated DRG
formation is a calcium-dependent process and closely as-
sociated with degranulation and oxidant release in adherent
PMN.
Effect of BAPTA/AM on PLD activity in adherent PMNs
plated onto fibrinogen
To confirm that the increase in DRG occurring coinciden-
tally with LF and H202 was generated through the action of












































Fig. 3. Effect of BAPTA on the formation of PEt in PMNs plated onto
fibrinogen. PMNs were labeled with [3H]lysoPAF. Labeled cells (1 x l05/nil)
were preincubated with ethanol (200 mM) or butler for 5 rain at 37#{176}Cand
then plated onto fibrinogen-coated 24-well plates containing 100 nM fMLP.
ill the presence or absence of BAPTA and ethanol. Samples were withdrawn
at the indicated times and assayed for PEt formation. Values represent the
mean ± SI) of three separate experiments.
on PMN functional responses. In the presence of ethanol,
PLD activation results in a transphosphatidylation reaction
80  that generates phosphatidylethanol rather than PA. Previ-
 ously, we found that IMLP-stimulated adherent PMNs
0 failed to release significant amounts of H202 or LF, or gener-
60 La ate the second wave of DRG, in the presence of ethanol [7].
c These previous results suggested that DRG generated
40 through the action of PLD is critical for degranulation and
 oxidant release in IMLP-stimulated adherent PMNs. In the
 current studies, we labeled cells with [3H]lysoPAF and meas-
20 F- ured PEt formation at 15 and 90 mm in control and BAPTA-
 treated PMNs after addition to fibrinogen-coated plates. We
_J then determined whether intracellular calcium chelation
0 l with BAPTA would prevent PLD activation. In the presence
of ethanol and absence of IMLP stimulation, there was a
modest increase in PEt formation at 90 mm (Fig. 3). fMLP
stimulation ofPMNs in the presence ofethanol did not affect
PEt formation at 15 mm but resulted in about a 13-fold in-
crease in PEt by 90 mm, corresponding to the second wave
of DRG formation. To determine whether the action of PLD
was Ca2 dependent, PMNs were incubated with 10 tM
BAPTA/AM. As noted in Figure 3, BAPTA-treated PMNs
were impaired in their ability to generate PEt at 90 mm fol-
lowing activation with fMLP. These results indicate that
BAPTA blocks DRG formation by chelating intracellular
Ca2, thereby preventing the PLD activity in the adherent
PMNs.
Effect of DiC1O on BAPTA/AM-treated PMNs
Because BAPTA treatment blocked the formation of DRG
generated through the action of a calcium-dependent PLD,
we assessed the effect ofexogenously added DiC1O on restor-
ing oxidant generation in the adherent PMNs (Fig. 4). We
observed that 50 jtM DiC1O by itself stimulated the cells to
release H202 upon addition of DiC1O 90 mm after BAPTA
treatment.
DISCUSSION
In the present study, we have focused on the effect of damp-







Fig. 2. Effect of ionomycin on reversing BAPTA inhibition of H202 and LF
release and DRG formation. (A) LF release and H202 release in PMNs in
the presence and absence of 10 jzM BAPTA. PMNs (1 x l05/ml) were added
to fibrinogen-coated 24-well plates containing either 100 nM fMLP (0, A)
or fMLP and 10 M BAPTA (#{149},A) incubated at 37#{176}Cuntil 90 mm. At
90 mm (indicated by arrow) 100 nM ionomycin was added to the BAPTA-
treated adherent PMNs. Throughout the study samples were withdrawn at
varying times and monitored for LF and H202 release. (B) In parallel wells,
DRG formation in both fMLP-stimulated (0) and IMLP-stimulated and
BAPTA-treated (#{149})PMNs was measured over the indicated times. At 90
mm, as indicated by the arrow, 100 nM ionomycin was added to the BAPTA-
treated PMNs. Values represent the mean ± SD of three separate experiments.
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Fig. 4. Effect ofDiClO on BAPTA-loaded PMNs. PMNs (1 x 105/ml) were
added to fibrinogen-coated 24-well plates containing 10 sM BAPTA in the
presence of 50 tM DiC1O (#{149}),which was added at 90 mm as indicated by
the arrow, or the absence of DiCIO (0). The plates were incubated at 3 7#{176}C,
and samples were withdrawn at varying times and monitored for H202
release. Values represent the mean ± SI) of three separate experiments.
in adherent human PMNs. Others have studied in more de-
tail the effect of changes in [Ca2]1 on PLD activation in
both intact and electropermeabilized PMNs in suspension
[13]. There appears to be an absolute requirement for a rise
in [Ca2]1 to induce PLD activation in intact or electroper-
meabilized suspended PMNs. However, in suspended,
IMLP-activated PMNs, PLD activation does not appear to
be required for induction of the respiratory burst [13]. In
contrast, we found that chelation of intracellular calcium
prevented PLD activation and the coincident release of LF-
containing specific granules and H202 from adherent PMNs.
Mammalian PLD is membrane bound and uses phos-
phatidylcholine as its primary substrate, although under cer-
tam conditions, phosphatidylethanolamine and phos-
phatidylinositol may be degraded [14]. PLD acting on
phosphatidylcholine exhibits two distinct enzymatic activi-
ties. In addition to the hydrolytic activity that generates
phosphatidic acid, PLD catalyzes a transphosphatidylation
reaction in the presence of primary alcohols in which the
phosphatidyl moiety of phosphatidylcholine is transferred to
a primary alcohol to produce phosphatidylalcohol [15]. In
this report, we observed that chelation of intracellular cal-
cium prevented PLD activation as monitored by inhibition
of PEt formation. It is not surprising then that generation of
DRG, derived from PA by activation of phosphatidic phos-
phohydrolase, was also prevented in the presence of BAPTA.
In contrast, the initial phase offormation ofDRG, likely der-
ived from PLC activation, was unaffected by intracellular
calcium chelation.
Following the addition of the calcium ionophore ionomy-
cm to the BAPTA-treated cells, LF and H202 release re-
sumed coincident with the onset of DRG formation. Studies
using cell-permeant short-chain DRG indicate that these
phospholipid products may be involved in degranulation, su-
peroxide generation, and protein kinase C activation by
PMNs in suspension [8]. Although the same studies indi-
cated that DiC1O will activate lysosomal release, DiC1O failed
to activate the respiratory burst and was a poor competitor
for [3H]PDBU binding to intact PMNs compared with other
short-chain DRG. These studies indicate that DiC1O stimu-
lated PMNs in suspension by means other than protein
kinase C activation [8]. In our study, however, DiC1O proved
to be a potent agonist for adherent PMNs by stimulating
these cells to release H202. Our studies continue to support
the notion that DRG, derived from PLD activation, is re-
quired for degranulation of specific granules and the as-
sociated release of H202 from adherent PMNs. In summary,
unlike PMNs in suspension, in which fMLP will preferen-
tially activate PLC to generate a respiratory burst, activated
adherent PMNs release H202 via a PLD-mediated pathway
[14, 16].
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